New aims and next steps for adult ALL induction therapy
Novel therapies in myeloma: selinexor, venetoclax, among others
Heinz Ludwig et al.
Daratumumab in the treatment of multiple myeloma
Exploiting signalling pathways involved in CLL to develop novel therapies
Conversations doctors must have with CLL patients